Target intelligence / Profile preview

Serine palmitoyltransferase, long chain base subunit 2 pseudogene

Molecular classification: Other (Pseudogene)

Overview

Serine palmitoyltransferase, long chain base subunit 2 pseudogene (LOC100422263, ENSG00000213065) is classified as a pseudogene, which means it is a genomic DNA sequence similar to a known gene but is non-functional; it does not encode a functional protein product. While its parental gene SPTLC2 encodes a catalytic subunit of the serine palmitoyltransferase enzyme crucial for sphingolipid biosynthesis—and mutations in SPTLC2 are implicated in inherited neuropathies—this pseudogene itself has no confirmed biological function, disease associations, or relevance as a therapeutic target.

Other names: LOC100422263ENSG00000213065SPTLC2 pseudogene

Beyond the preview

Go deeper on Serine palmitoyltransferase, long chain base subunit 2 pseudogene.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Serine palmitoyltransferase, long chain base subunit 2 pseudogene.

Explore the full profile